UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934 (Amendment No. )
Filed by the Registrant ý | ||
Filed by a Party other than the Registrant o |
||
Check the appropriate box: |
||
o |
|
Preliminary Proxy Statement |
o |
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
ý |
|
Definitive Proxy Statement |
o |
|
Definitive Additional Materials |
o |
|
Soliciting Material under §240.14a-12 |
ALLIED WORLD ASSURANCE COMPANY HOLDINGS, AG | ||||
(Exact name of Registrant as Specified In Its Charter) |
||||
(Name of Person(s) Filing Proxy Statement, if other than the Registrant) |
||||
Payment of Filing Fee (Check the appropriate box): |
||||
ý |
|
No fee required. |
||
o |
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. |
||
| (1) | | Title of each class of securities to which transaction applies: |
|
| (2) | | Aggregate number of securities to which transaction applies: |
|
| (3) | | Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined): |
|
| (4) | | Proposed maximum aggregate value of transaction: |
|
| (5) | | Total fee paid: |
|
o |
|
Fee paid previously with preliminary materials. |
||
o |
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. |
||
|
(1) |
|
Amount Previously Paid: |
|
| (2) | | Form, Schedule or Registration Statement No.: |
|
| (3) | | Filing Party: |
|
| (4) | | Date Filed: |
ALLIED WORLD ASSURANCE COMPANY HOLDINGS, AG
Park Tower, 15th floor, Gubelstrasse 24
6300 Zug, Switzerland
February 22, 2017
Dear Shareholder:
We are pleased to invite you to attend the extraordinary general meeting of shareholders of Allied World Assurance Company Holdings, AG (Allied World, the company, we, our or us), a Swiss corporation, which will be held at Allied Worlds corporate headquarters, Park Tower, 15th floor, Gubelstrasse 24, 6300 Zug, Switzerland, on March 22, 2017, at 2:00 p.m., local time (the Special Shareholder Meeting).
The Special Shareholder Meeting is being called to vote on the items described below in connection with the proposed exchange offer (the offer) by a wholly-owned subsidiary (Bid Sub) of Fairfax Financial Holdings Limited, a corporation existing under the laws of Canada (Fairfax), to acquire all of the outstanding common shares, par value CHF 4.10 per share, of Allied World (common shares), pursuant to the terms, and subject to the conditions, of that certain Agreement and Plan of Merger, dated as of December 18, 2016, between Fairfax and Allied World, as may be amended from time to time.
At the Special Shareholder Meeting, holders of our common shares will be asked to consider and vote on: (i) a proposal to amend Articles 8 and 14 of the companys Articles of Association to remove the limitation on the voting rights of a holder of 10% or more of our common shares (the Amendment Proposal); and (ii) a proposal for Allied World to pay, as soon as possible after the closing of the offer, a special dividend of $5.00 per common share to holders of our outstanding common shares as of immediately prior to the closing of the offer and to forgo the $0.26 quarterly dividend (the Special Dividend Proposal). Each proposal is conditioned on the closing of the offer.
The Board unanimously recommends that the shareholders of the company vote FOR the Amendment Proposal and vote FOR the Special Dividend Proposal.
Completion of the offer is conditioned on, among other things, the approval of each of these proposals. Please note that by voting on these proposals, you are not making a decision with respect to the offer. You will have the opportunity to elect whether to tender your shares in the offer at a later date once the offer is commenced. See Important Note Regarding the Special Shareholder Meeting.
Your vote is very important. Whether or not you expect to attend in person, we urge you to submit a proxy to vote your shares as promptly as possible by signing and returning the enclosed proxy card in the postage-paid envelope provided, so that your shares may be represented and voted at the Special Shareholder Meeting. If your shares are held in an Allied World plan or in the name of a bank, brokerage firm or other nominee, please follow the instructions on the voting instruction card furnished by the plan trustee or administrator, or record holder, as appropriate.
If you have any questions or need assistance in voting your shares, please contact our proxy solicitor, Georgeson LLC, at (800) 248-7690.
Thank you for your continued support.
| Sincerely, | |
|
||
|
Scott A. Carmilani Chairman, President and Chief Executive Officer Allied World Assurance Company Holdings, AG |
ALLIED WORLD ASSURANCE COMPANY HOLDINGS, AG NOTICE OF SPECIAL SHAREHOLDER MEETING |
February 22, 2017
DATE: | | Wednesday, March 22, 2017 |
TIME: | | 2:00 p.m., local time |
PLACE: | | Corporate headquarters: Park Tower, 15th floor, Gubelstrasse 24, 6300 Zug, Switzerland |
ITEMS OF BUSINESS:
RECORD DATE: | | Only shareholders of record holding common shares, as shown on our transfer books, as of the close of business on February 17, 2017 are entitled to vote at the Special Shareholder Meeting. |
MATERIALS TO REVIEW: |
|
This document contains our Notice of Special Shareholder Meeting and Proxy Statement. |
PROXY VOTING: |
|
It is important that your shares be represented and voted at the Special Shareholder Meeting. Please promptly sign, date and return the enclosed proxy card in the return envelope furnished for that purpose whether or not you plan to attend the meeting. If you later desire to revoke your proxy for any reason, you may do so in the manner described in the attached proxy statement. |
| By Order of the Board of Directors, | |
| ||
| Theodore Neos Corporate Secretary |
IMPORTANT NOTE REGARDING THE SPECIAL SHAREHOLDER MEETING |
While the closing of the offer is conditioned on (among other things) the approval of the Amendment Proposal and the Special Dividend Proposal, shareholders should be aware that a vote in favor of the Amendment Proposal or the Special Dividend Proposal at the Special Shareholder Meeting is not a vote in favor of, or a tender of our common shares into, the offer. The offer has not commenced. At the time the offer is commenced, Fairfax will file with the U.S. Securities and Exchange Commission (the SEC): (i) a registration statement on Form F-4, which will include a prospectus of Fairfax in respect of the Fairfax shares to be issued in the offer; and (ii) a tender offer statement on Schedule TO (together with related documents, including an offer to exchange and a related form of letter of transmittal), and Allied World will file with the SEC a Solicitation/Recommendation Statement on Schedule 14D-9 with respect to the offer. These documents will contain important information about the offer that should be read carefully before any decision is made with respect to the offer. By voting on the proposals in this proxy statement, you are not making a decision with respect to the offer. You will have the opportunity to elect whether to tender your shares in the offer at a later date once the offer is commenced.
-2-
PROXY STATEMENT
-3-
|
| Proposal
|
| Vote Required
|
| Effect of Abstentions |
| Effect of Broker Non-Votes |
---|---|---|---|---|---|---|---|---|
|
|
|
|
|||||
1 | | Amendment Proposal | | 2/3 of shares represented(1) | | Vote against | | Vote not counted |
2 |
|
Special Dividend Proposal |
|
Majority of votes cast(2) |
|
Vote not counted |
|
Vote not counted |
-4-
-5-
-6-
-7-
Organizational Matters Required by Swiss Law |
Admission to the Special Shareholder Meeting
Shareholders who are registered in our share register on the Record Date will receive the Proxy Statement and proxy card from Continental Stock Transfer & Trust Company, our transfer agent. Beneficial owners of shares will receive instructions from their bank, brokerage firm or other nominee acting as shareholder of record to indicate how they wish their shares to be voted. Beneficial owners who wish to vote in person at the Special Shareholder Meeting must obtain a power of attorney from their bank, brokerage firm or other nominee that authorizes them to vote the shares held by them on their behalf. In addition, you must bring to the Special Shareholder Meeting an account statement or letter from your bank, brokerage firm or other nominee indicating that you are the owner of the common shares. Shareholders of record registered in our share register are entitled to participate in and vote at the Special Shareholder Meeting. Each share is entitled to one vote. The exercise of voting rights is subject to the voting restrictions set out in the companys Articles of Association, a summary of which is contained in How many votes do I have? Please see the questions and answers provided under Special Meeting Information for further information.
Granting a Proxy
If you are a shareholder of record, please see How do I vote? and How do I appoint and vote via an independent proxy if I am a shareholder of record? above in the Proxy Statement for more information on appointing an independent proxy.
Registered shareholders who have appointed the independent proxy as a proxy may not vote in person at the Special Shareholder Meeting or send a proxy of their choice to the meeting unless they revoke or change their proxies. Revocations to the independent proxy must be received by him by no later than 6:00 a.m., local time, on March 22, 2017 either by mail to Buis Buergi AG, Muehlebachstrasse 8, P.O. Box 672, CH-8024 Zurich, Switzerland or by e-mail at proxy@bblegal.ch.
As indicated on the proxy card, with regard to the items listed on the agenda and without any explicit instructions to the contrary, the independent proxy will vote according to the recommendations of the Board. If new agenda items (other than those on the agenda) or new proposals or motions regarding agenda items set out in the invitation to the Special Shareholder Meeting are being put forth before the meeting, the independent proxy will vote in accordance with the position of the Board in the absence of other specific instructions.
Beneficial owners who have not obtained a power of attorney from their bank, brokerage firm or other nominee are not entitled to participate in or vote at the Special Shareholder Meeting.
Admission Office
The admission office opens on the day of the Special Shareholder Meeting at 1:30 p.m. local time. Shareholders of record attending the meeting are kindly asked to present their proxy card as proof of admission at the entrance.
Adjournments
The Board or chairman of the Board may postpone the Special Shareholder Meeting with sufficient factual reason, provided that notice of postponement is given to the shareholders in the same form as the invitation before the time for such meeting. A new notice is then required to hold the postponed meeting.
-8-
Recent Developments: Merger Agreement with Fairfax |
Bid Sub will offer to acquire all of the outstanding common shares of Allied World upon the terms and subject to the conditions set out in the the Agreement and Plan of Merger, dated as of December 18, 2016, between Fairfax and Allied World, as may be amended from time to time (the Merger Agreement).
Pursuant to the Merger Agreement, Allied World shareholders will be offered a combination of cash and stock consideration for each common share, including:
| · |
| cash consideration of $5.00, without interest (the Cash Consideration); |
| · |
| a special cash dividend of $5.00, without interest, payable as soon as possible after the Acceptance Time (as defined below) to holders of common shares as of immediately prior to the Acceptance Time; |
| · |
| a portion of the stock consideration of fully paid and nonassessable subordinate voting shares of Fairfax (Fairfax Shares) having a value of $14.00 based on the closing price of Fairfax as of December 16, 2016 (the Fairfax Closing Price), payable at a fixed exchange ratio of 0.030392 (the Fixed Exchange Stock Consideration); and |
| · |
| the remaining portion of the stock consideration equal to the quotient of (x) $30.00 and (y) the volume weighted average closing price of Fairfax shares on the Toronto Stock Exchange (the TSX) for the 20 consecutive trading days immediately preceding the trading day before the date on which Bid Sub first accepts tendered common shares for exchange (the Acceptance Time), converted from Canadian dollars to U.S. dollars using the average Bank of Canada USD/CAD noon exchange rate over such 20-day period, rounded to the nearest one-hundredth of one cent (provided that this volume weighted average price is greater than $435.65 and less than $485.65 per Fairfax Share) (the Fixed Value Stock Consideration). If this volume weighted average price of Fairfax Shares during this period is greater than or equal to $485.65 per Fairfax Share, this portion of the consideration will be fixed at 0.061772 Fairfax Shares for each common share. If this volume weighted average price of Fairfax shares during this period is less than or equal to $435.65 per Fairfax Share, this portion of the consideration will be fixed at 0.068862 Fairfax shares for each common share. Fairfax may elect, in its sole discretion, at any time on or prior to March 3, 2017, to increase the amount of the Cash Consideration from $5.00 to an amount not exceeding $35.00, which will correspondingly serve to reduce the Fixed Value Stock Consideration. |
If, following completion of the offer, Fairfax has acquired or controls, directly or indirectly, at least 90% of all outstanding common shares of the company (excluding shares held by the company), no actions or proceedings are pending with respect to the exercisability of the voting rights associated with those common shares and no other legal impediment to a squeeze-out merger under Swiss law exists, Fairfax will, subject to the satisfaction or waiver of the other conditions set forth in the Merger Agreement, indirectly through a company to be incorporated under the laws of Switzerland and an indirect wholly-owned subsidiary of Fairfax (Merger Sub), effect a squeeze-out merger under Swiss law (the Squeeze-Out Merger). The Squeeze-Out Merger will be effected pursuant to a merger agreement to be entered into by Allied World, Bid Sub and Merger Sub, whereby any remaining holders of our common shares (except for Allied World, Fairfax, Bid Sub and Merger Sub, which will not receive any compensation for any Allied World shares directly or indirectly held by them) will receive the same consideration described above in exchange for such common shares.
-9-
The obligation of Fairfax to consummate the offer is subject to other conditions, including (i) approval by Allied Worlds shareholders of the Amendment Proposal and the Special Dividend Proposal; (ii) approval by Allied Worlds shareholders to elect the individuals designated by Fairfax to Allied Worlds board of directors upon or after completion of the offer, such approval to be addressed in a separate proxy statement in connection with a vote at a separate special shareholder meeting, as may be waived by Fairfax; (iii) to the extent required by applicable laws and regulations (based on the total number of Fairfax Shares to be issued as consideration for the transactions), approval by Fairfaxs shareholders of the issuance of Fairfax Shares as consideration for the transactions; (iv) a number of our common shares having been validly tendered and not properly withdrawn that represents 90% of our common shares outstanding (provided that, in the event all of the other conditions to the offer have been satisfied or waived, Fairfax, through Bid Sub, may elect in its sole and absolute discretion to reduce the 90% threshold to 662/3%); (v) receipt of governmental consents and approvals required to consummate the transactions; and (vi) other customary conditions set forth in the Merger Agreement. The obligation of each party to consummate the transactions is also conditioned upon the other partys representations and warranties being true and correct and the other party having performed in all material respects its obligations under the Merger Agreement.
The Merger Agreement provides for certain payments upon termination of the Merger Agreement under specified circumstances. If the Merger Agreement is terminated by Allied World or Fairfax as a result of an adverse change in the recommendation of the other partys board of directors, Allied World may be required to pay to Fairfax, or Fairfax may be required to pay to Allied World, a termination fee of $196 million.
Shareholders should be aware that a vote in favor of any of these proposals, including the Amendment Proposal and the Special Dividend Proposal, is not a vote in favor of, or a tender of our common shares into, the offer. The offer has not commenced. At the time the offer is commenced, Fairfax will file with the SEC: (i) a registration statement on Form F-4, which will include a prospectus of Fairfax in respect of the Fairfax shares to be issued in the offer; and (ii) a tender offer statement on Schedule TO (together with related documents, including an offer to exchange and a related form of letter of transmittal), and Allied World will file with the SEC a Solicitation/Recommendation Statement on Schedule 14D-9 with respect to the offer. These documents will contain important information about the offer that should be read carefully before any decision is made with respect to the offer. By voting on the proposals in this proxy statement, you are not making a decision with respect to the offer. You will have the opportunity to elect whether to tender your shares in the offer at a later date once the offer is commenced.
For a more complete description of the Merger Agreement and the transactions contemplated thereby, see our Current Report on Form 8-K filed on December 20, 2016 with the SEC (including the complete text of the Merger Agreement, which is attached as Exhibit 2.1 thereto).
-10-
PROPOSAL 1 AMEND THE ARTICLES OF ASSOCIATION TO REMOVE THE LIMITATION ON THE VOTING RIGHTS OF A HOLDER OF 10% OR MORE OF THE COMPANYS COMMON SHARES |
Pursuant to the Merger Agreement, the company has agreed to submit a proposal to the companys shareholders to amend Article 14 of the Articles of Association to permit a holder of 10% or more of our common shares to register its common shares on the companys shareholder register with full voting rights for all shares held by such holder (or any of its affiliates or controlled persons as defined in Article 14 of the Articles of Association). The Board proposes that the shareholders amend Article 14 of the Articles of Association so that subparagraphs b), c), e) and f) will be deleted and not replaced and amend certain subparagraphs of Article 8 of the Articles of Association that refer to subparagraphs b), c), e) and f) of Article 14 of the Articles of Association. These amendments will provide assurance to Fairfax that Bid Sub or any other Fairfax-controlled company that holds common shares will, subject to and immediately upon the closing of the offer, be registered as a shareholder of Allied World with voting rights for all shares acquired in the offer or otherwise held by it. Under the current Articles of Association, holders of controlled shares that constitute 10% or more of our issued common shares have limited voting rights with respect to such controlled shares. Such voting right is limited, in the aggregate, to a voting power of approximately 10% pursuant to a formula specified in Article 14 of the Articles of Association. The Articles of Association define controlled shares generally to include all common shares directly, indirectly or constructively owned or beneficially owned by any person or group of persons.
Pursuant to Swiss law, we are required to submit to you for your approval both the English version and the (authoritative) German version of the proposed amendments to the Articles of Association. Upon the approval of this proposal, Articles 8 and 14 of the Articles of Association will be amended to read as follows:
Artikel 8 Aktienregister und Beschränkungen der Übertragbarkeit | | Article 8 Share Register and Transfer Restrictions | ||||||||||||||||
a) |
|
Für die Namenaktien wird ein Register (Aktienbuch) geführt. Darin werden die Eigentümer und Nutzniesser mit Namen und Vornamen, Wohnort, Adresse und Staatsangehörigkeit (bei juristischen Personen mit Sitz) eingetragen. |
|
a) |
|
Registered shares are registered in a share register. The name of the owner or the usufructuary shall be entered in the share register with his/her name, address, domicile and citizenship (domicile in case of legal entities). |
||||||||||||
b) |
|
Zur Eintragung ins Aktienbuch als Aktionär mit Stimmrecht ist die Zustimmung des Verwaltungsrats notwendig. Die Eintragung als Aktionär mit Stimmrecht kann in den in Artikel 8 lit. |
|
b) |
|
Entry in the share register of registered shares with voting rights is subject to the approval of the Board of Directors. Entry of registered shares with voting rights may be refused based on the grounds set out in Article 8 paragraph |
||||||||||||
|
|
|
|
|
|
|
|
|
-11-
| Aktionäre ohne Stimmrecht ins Aktienbuch eingetragen. Die entsprechenden Aktien gelten in der Generalversammlung als nicht vertreten. | | | the share register as shareholders without voting rights. The corresponding shares shall be considered as not represented in the General Meeting of Shareholders. | ||||||||||||||
c) |
|
[gelöscht] |
|
c) |
|
[deleted] |
||||||||||||
d) |
|
[reserviert] |
|
d) |
|
[reserved] |
||||||||||||
e) |
|
[gelöscht] |
|
e) |
|
[deleted] |
||||||||||||
f) |
|
Der Verwaltungsrat verweigert die Eintragung ins Aktienbuch als Aktionär mit Stimmrecht oder entscheidet über die Löschung eines bereits eingetragenen Aktionärs mit Stimmrecht aus dem Aktienbuch, wenn der Erwerber auf sein Verlangen hin nicht ausdrücklich erklärt, dass er die Aktien im eigenen Namen und auf eigene Rechnung erworben hat. |
|
f) |
|
The Board of Directors shall reject entry of registered shares with voting rights in the share register or shall decide on their cancellation when the acquirer or shareholder upon request does not expressly state that he/she has acquired or holds the shares in his/her own name and for his/her own account. |
||||||||||||
g) |
|
Der Verwaltungsrat verweigert die Eintragung natürlicher und juristischer Personen, welche Namenaktien für Dritte halten und dies schriftlich gegenüber der Gesellschaft erklären, als Treuhänder/Nominees mit unbeschränktem |
|
g) |
|
The Board of Directors shall reject entry of individuals and legal entities who hold registered shares for third parties and state this in writing to the Company, as nominees in the share register with voting rights without |
||||||||||||
|
|
|
|
|
|
|
|
|
-12-
| Stimmrecht ins Aktienbuch oder entscheidet über die Löschung aus dem Aktienbuch, wenn sie sich nicht dazu verpflichten, gegenüber der Gesellschaft auf deren schriftliches Verlangen hin jederzeit die Namen, Adressen und Beteiligungsquoten derjenigen Personen offenzulegen, für welche sie die Namenaktien halten. | | | limitation or shall decide on their cancellation when the nominee does not undertake the obligation to disclose at any time to the Company at its written request the names, addresses and share holdings of each person for whom such nominee is holding shares. | ||||||||||||||
h) |
|
Der Verwaltungsrat kann in besonderen Fällen Ausnahmen von den obgenannten Beschränkungen (Artikel 8 lit. |
|
h) |
|
The Board of Directors may in special cases approve exceptions to the above regulations (Article 8 paragraph |
||||||||||||
i) |
|
Solange ein Erwerber nicht Aktionär mit Stimmrecht im Sinne von Artikel 8 der Statuten geworden ist, kann er weder die entsprechenden Stimmrechte noch die weiteren mit diesem in Zusammenhang stehenden Rechte wahrnehmen. |
|
i) |
|
Until an acquirer becomes a shareholder with voting rights for the shares in accordance with this Article 8 of the Articles of Association, he/she may neither exercise the voting rights connected with the shares nor other rights associated with the voting rights. |
||||||||||||
Artikel 14 Stimmrecht und Vertreter |
|
Article 14 Voting Rights and Shareholders Proxies |
||||||||||||||||
a) |
|
Jede Aktie berechtigt, unter Vorbehalt der Einschränkungen gemäss Artikel 8 der Statuten |
|
a) |
|
Each share is entitled to one vote subject to the provisions of Article 8 of the Articles of Association |
||||||||||||
b) |
|
[gelöscht] |
|
b) |
|
[deleted] |
||||||||||||
|
|
|
|
|
|
|
|
|
-13-
|
|
| |
|
||||||||||||||
|
|
|
||||||||||||||||
|
|
|
|
|
||||||||||||||
c) |
|
[gelöscht] |
|
c) |
|
[deleted] |
||||||||||||
|
|
|
|
|
||||||||||||||
|
|
|
|
|
||||||||||||||
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
-14-
| | | |
|
| | | | |
|
||||||||
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
-15-
| |
|
|
|
| | |
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
-16-
| | | |
|
| | | | | |||||||||
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
|
-17-
| | |
|
| | | |
|
||||||||||
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
-18-
| | | |
|
| | | | |
|
||||||||
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
-19-
d) | | Die Generalversammlung wählt einen unabhängigen Stimmrechtsvertreter und einen Stellvertreter. Wählbar sind natürliche oder juristische Personen oder Personengesellschaften. Die Unabhängigkeit richtet sich nach Artikel 728 OR. Die Amtsdauer des unabhängigen Stimmrechtsvertreters und etwaiger Stellvertreter endet mit der Beendigung der auf ihre Wahl folgenden ordentlichen Generalversammlung. Wiederwahl ist möglich. Falls der unabhängige Stimmrechtsvertreter vor Ablauf seiner Amtsdauer aus seinem Amt ausscheidet, seine Unabhängigkeit verliert oder sein Amt nicht ausüben kann, übernimmt sein von der Generalversammlung gewählter Stellvertreter ohne weiteres seine Funktion. Der unabhängige Stimmrechtsvertreter nimmt seine Pflichten in Übereinstimmung mit den einschlägigen Gesetzesvorschriften wahr. Der Verwaltungsrat stellt sicher, dass die Aktionäre die Möglichkeit haben, dem unabhängigen Stimmrechtsvertreter zu jedem in der Einberufung gestellten Antrag zu Verhandlungsgegenständen Weisungen zu erteilen. Zudem müssen sie die Möglichkeit haben, zu nicht angekündigten Anträgen zu Verhandlungsgegenständen sowie zu neuen Verhandlungsgegenständen gemäss Artikel 700 Absatz 3 OR allgemeine Weisungen zu erteilen. Der Verwaltungsrat stellt sicher, dass die Aktionäre ihre Vollmachten und Weisungen, auch elektronisch, bis 6 Uhr Lokalzeit am Tag der Generalversammlung dem unabhängigen Stimmrechtsvertreter erteilen können. Der unabhängige Stimmrechtsvertreter ist verpflichtet, die ihm von den Aktionären übertragenen Stimmrechte weisungsgemäss auszuüben. Hat er keine Weisungen erhalten, so enthält er sich der Stimme. Kann der unabhängige Stimmrechtsvertreter sein Amt nicht ausüben, dann gelten die ihm erteilten Vollmachten und Weisungen als seinem Stellvertreter erteilt. | | d) | | The General Meeting of Shareholders shall elect an Independent Proxy and a substitute of the Independent Proxy who may either be individuals, legal entities or partnerships. The independence of the Independent Proxy and his, her or its substitute shall be construed in accordance with Article 728 CO. The term of the Independent Proxy and his, her or its substitute shall end with the closing of the next ordinary General Meeting of Shareholders following the General Meeting of Shareholders that elected the Independent Proxy and his, her or its substitute. The Independent Proxy and his, her or its substitute may be re-elected. In case the Independent Proxy leaves office before the end of its term, if he, she or it loses his, her or its independence or may otherwise no longer exercise his, her or its functions, the substitute to be elected by the General Meeting of Shareholders shall assume the office. The Independent Proxy shall exercise his, her or its responsibilities in accordance with the provisions of the law. The Board of Directors shall ensure that the shareholders have the opportunity to give instructions to the Independent Proxy with respect to each agenda point mentioned in the notice to the meeting. In addition, the shareholders shall be given the opportunity to give general instructions with respect to motions made at the meeting concerning an agenda point or with respect to an agenda point not previously announced in the invitation (Article 700 para. 3 CO). Furthermore, the Board of Directors shall ensure that the shareholders may give their proxy or instructions to the Independent Proxy until 6:00 a.m. (local time) on the day of the General Meeting. The Independent Proxy shall exercise the voting rights granted to him, her or it by the shareholders in accordance with their instructions. If no instructions have been given, the Independent Proxy shall abstain from voting. If the Independent Proxy is unable to exercise his, her or its office, the proxies and instructions shall be deemed to be given to the substitute of the Independent Proxy. | ||||||||||||
|
|
|
|
|
|
|
|
|
-20-
e) | |
[gelöscht] |
| e) | |
[deleted] |
||||||||||||
f) |
|
[gelöscht] |
|
f) |
|
[deleted] |
This proposal is conditioned upon the closing of the offer, which is also subject to other conditions. Please see Recent Developments: Merger Agreement with Fairfax in this proxy statement for further discussion of the conditions to the closing of the offer.
The vote on the Amendment Proposal is a vote separate and apart from the vote to approve the Special Dividend Proposal. Accordingly, you may vote to approve the Amendment Proposal and vote not to approve the Special Dividend Proposal or vice versa. The Amendment Proposal will only be implemented after each of the conditions to the offer as set forth in the Merger Agreement is satisfied or waived, and immediately prior to when the common shares are exchanged pursuant to the offer. The approval of the Amendment Proposal is a condition to the consummation of the offer. If the Amendment Proposal is not approved, the offer will not be consummated, and consequently, the Special Dividend Proposal, even if approved, will not be implemented. If the shareholders do not approve this proposal, the Board may call another special meeting of shareholders for reconsideration of this proposal.
The approval of the above amendments to Articles 8 and 14 of the Articles of Association requires the affirmative vote of at least two thirds of the votes represented at the Special Shareholder Meeting and a majority of the par value of our common shares represented at such meeting, where two or more persons are present in person and representing in person or by proxy at least 50% of our total issued and outstanding common shares.
Your Board unanimously recommends a vote FOR the amendment of Articles 8 and 14 of the Articles of Association as described in this proposal.
-21-
PROPOSAL 2 APPROVE THE PAYMENT OF A $5.00 SPECIAL DIVIDEND AND FORGO THE $0.26 QUARTERLY DIVIDEND |
Pursuant to the Merger Agreement, the company has agreed to submit a proposal to the companys shareholders to approve the declaration and payment of a special dividend of $5.00 per common share, payable, without interest, as soon as possible after such time that our common shares tendered pursuant to the offer are accepted for exchange by Bid Sub, to the holders of record of our outstanding common shares as of immediately prior to the Acceptance Time. The Board proposes that the shareholders approve the special dividend in the form of a distribution out of the general legal reserve from capital contributions. A report from our statutory auditor, Deloitte AG, will be available at the Special Shareholder Meeting to confirm that the payment of the special dividend will be in accordance with Swiss law and our Articles of Association, subject to the completion of the required audit procedures. The special dividend amount of $5.00 per common share, which is approximately equal to CHF 5.014 per share using the USD/CHF currency exchange rate as reported by the Wall Street Journal on February 20, 2017, will be paid in U.S. dollars.
At the annual shareholder meeting of the company on April 19, 2016, the shareholders approved a distribution to shareholders in an aggregate CHF amount equal to $1.04 per share, due and payable in four quarterly installments of $0.26 per share each in July 2016, October 2016, December 2016 and March 2017. As part of this proposal, shareholders are being asked to approve the use of the $0.26 March 2017 quarterly dividend for the payment of the special dividend, conditioned upon the occurrence of the Acceptance Time. If the proposed use of the fourth dividend installment is approved, any Aggregate Dividend Amount From Capital Contributions Reserves remaining after the payment of the first, second and third dividend installments and the $5.00 special dividend will, in accordance with the shareholder resolution adopted at the annual shareholder meeting of the company on April 19, 2016, be reallocated to the general legal reserve from capital contributions account included in the balance sheet of the companys Swiss statutory financial statements.
The Board unanimously recommends that the companys shareholders approve the following resolution:
RESOLVED, that the shareholders of Allied World Assurance Company Holdings, AG (the Company), hereby approve (i) subject to such time that the Companys ordinary shares, par value CHF 4.10 per share (Common Shares), tendered pursuant to the offer are accepted for exchange (the Acceptance Time) and the restrictions of Swiss law, the declaration and payment of a special dividend of $5.00 per Common Share payable, without interest, out of the general legal reserve from capital contributions to holders of record of outstanding Common Shares as of immediately prior to the Acceptance Time, as soon as possible after the Acceptance Time; and (ii) the use of the $0.26 quarterly dividend for the payment of the special dividend, also conditioned upon the occurrence of the Acceptance Time.
Pursuant to the Merger Agreement, any equity awards granted under our equity-related award plans, agreements and programs will be cancelled at the Acceptance Time and automatically converted into the right to receive an amount in cash equal to the aggregate consideration for each common share held, which includes the $5.00 special dividend. Please see Recent Developments: Merger Agreement with Fairfax in this proxy statement for further discussion of the merger consideration for each Allied World common share.
-22-
This proposal is conditioned upon the closing of the offer, which is also subject to other conditions. Please see Recent Developments: Merger Agreement with Fairfax in this proxy statement for further discussion of the conditions to the closing of the offer.
The vote on the Special Dividend Proposal is separate and apart from the vote to approve the Amendment Proposal. Accordingly, you may vote to approve the Special Dividend Proposal and vote not to approve the Amendment Proposal or vice versa. The approval of the Special Dividend Proposal is a condition to the consummation of the offer. If the Special Dividend Proposal is not approved, the offer will not be consummated, and consequently, the Amendment Proposal, even if approved, will not be implemented. If the shareholders do not approve this proposal, the Board may call another special meeting of shareholders for reconsideration of this proposal. If the Special Dividend Proposal is approved but the offer is not consummated, the $0.26 quarterly dividend for the first quarter of 2017 will be paid out as determined at the annual shareholder meeting of the company on April 19, 2016 and thereafter promptly paid to holders of our common shares as of February 17, 2017, the record date, without interest.
The approval of the Special Dividend Proposal requires the affirmative vote of the simple majority of the votes cast at the Special Shareholder Meeting, where two or more persons are present in person and representing in person or by proxy at least 50% of our total issued and outstanding common shares.
Your Board unanimously recommends a vote FOR the payment of a $5.00 special dividend and forgoing the $0.26 quarterly dividend, in each case conditioned upon the closing of the offer.
-23-
PRINCIPAL SHAREHOLDERS |
The table below sets forth information as of February 15, 2017 (except where noted below) regarding the beneficial ownership of our common shares by:
| · |
| each person known by us to beneficially own more than 5% of our outstanding common shares, |
| · |
| each of our directors, |
| · |
| our Chief Executive Officer (CEO), our Chief Financial Officer (CFO) and our three other most highly compensated officers who were serving as executive officers at the end of our 2016 fiscal year (collectively, our named executive officers or NEOs), and |
| · |
| all of our directors and executive officers as a group. |
Name and Address of Beneficial Owner |
| Beneficial Owner of Common Shares(1) |
|||||
| | | | | |||
|
| Number of Common Shares |
| Percentage of Common Shares |
|||
---|---|---|---|---|---|---|---|
| | | | | |||
Champlain Investment Partners, LLC(2) |
| | 4,713,355 |
| | 5.4% |
|
FMR LLC(3) |
|
|
7,343,323 |
|
|
7.1% |
|
The Vanguard Group, Inc.(4) |
| | 6,543,683 |
| | 7.5% |
|
Barbara T. Alexander |
| |
26,095 |
(5) |
|
* |
|
Scott A. Carmilani |
| | 1,540,923 |
(6) |
|
1.8% |
|
Bart Friedman |
| |
44,275 |
|
|
* |
|
Patricia L. Guinn |
| | 2,851 |
| | * |
|
Fiona E. Luck |
| |
2,853 |
|
|
* |
|
Patrick de Saint-Aignan |
| | 29,290 |
| | * |
|
Eric S. Schwartz |
| |
111,740 |
(7) |
|
* |
|
Samuel J. Weinhoff |
| | 42,169 |
| | * |
|
Thomas A. Bradley |
| |
17,936 |
|
|
* |
|
John R. Bender |
| | 151,622 |
(8) |
|
* |
|
Wesley D. Dupont |
| |
232,882 |
(9) |
|
* |
|
Frank N. DOrazio |
| | 228,059 |
(10) |
|
* |
|
All directors and executive officers as a group (18 persons) |
| |
2,873,004 |
(11) |
|
3.3% |
-24-
warrant or right. As of February 15, 2017, we had 87,176,849 common shares issued and outstanding. All amounts listed represent sole voting and dispositive power unless otherwise indicated.
OTHER MATTERS |
Your Board does not know of any matters that may be presented at the Special Shareholder Meeting other than those specifically set forth in the Notice of Special Shareholder Meeting attached hereto. If matters other than those set forth in the Notice of Special Shareholder Meeting come before the meeting, the persons named in the accompanying form of proxy and acting thereunder will vote in their discretion with respect to such matters.
-25-
EXTRAORDINARY GENERAL MEETING OF
SHAREHOLDERS
OF
ALLIED WORLD ASSURANCE COMPANY HOLDINGS, AG
2:00 p.m. (Swiss Local Time)
MARCH 22, 2017
PARK TOWER, 15TH FLOOR
GUBELSTRASSE 24
6300 ZUG, SWITZERLAND
PROXY
ALLIED WORLD ASSURANCE COMPANY HOLDINGS, AG
Meeting Details
PROXY SOLICITED BY THE BOARD OF DIRECTORS OF ALLIED WORLD ASSURANCE COMPANY HOLDINGS, AG IN CONNECTION WITH THE COMPANYS EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON MARCH 22, 2017 (THE SPECIAL SHAREHOLDER MEETING) AT 2:00 P.M. (SWISS LOCAL TIME) AT PARK TOWER, 15TH FLOOR, GUBELSTRASSE 24, 6300 ZUG, SWITZERLAND.
The undersigned shareholder of the company hereby acknowledges receipt of the Notice of Special Shareholder Meeting and Proxy Statement, each dated February 22, 2017, and hereby appoints Buis Buergi AG, as Independent Proxy, with the power to appoint its substitute, and authorizes the firm to represent and vote as designated herein, all of the voting registered shares of the company held of record on February 17, 2017 by the undersigned shareholder of the company at the Special Shareholder Meeting with respect to the matters listed on this Proxy.
Return this proxy to Buis Buergi AG, Muehlebachstrasse 8, P.O. Box 672, CH-8024, Zurich, Switzerland or by e-mail to proxy@bblegal.ch, for arrival no later than 6:00 a.m. (Swiss local time) on March 22, 2017. The method of delivery of this proxy is at your risk. Sufficient time should be allowed to ensure timely delivery. If sending by e-mail to the independent proxy, you must attach the executed proxy card in order for your vote to be counted. By executing and returning this proxy, the undersigned shareholder also agrees that the Special Shareholder Meeting will be chaired by Mr. Wesley D. Dupont, the companys Executive Vice President & General Counsel, in accordance with Article 13 of the companys Articles of Association.
PLEASE BE SURE TO SIGN AND DATE THIS PROXY
(Continued, and to be marked, dated and signed as instructed on the other side)
PROXY FOR ALLIED WORLD ASSURANCE COMPANY HOLDINGS, AG SPECIAL SHAREHOLDER MEETING ON MARCH 22, 2017. THE SUBMISSION OF THIS PROXY, IF PROPERLY EXECUTED, REVOKES ALL PRIOR PROXIES.
YOUR BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE FOR EACH PROPOSAL BELOW.
Please mark your votes like this x
1. To amend the Articles of Association to remove the limitation on the voting rights of a holder of 10% or more of the companys common shares.
|
|
FOR |
|
AGAINST |
|
ABSTAIN |
|
|
|
|
|
|
|
|
|
o |
|
o |
|
o |
2. To approve the payment of a $5.00 special dividend and forgo the $0.26 quarterly dividend.
|
|
FOR |
|
AGAINST |
|
ABSTAIN |
|
|
|
|
|
|
|
|
|
o |
|
o |
|
o |
Any new proposals (if no instruction or an unclear instruction is given, your vote will be in accordance with the recommendation of the Board of Directors).
|
|
FOR |
|
AGAINST |
|
ABSTAIN |
|
|
|
|
|
|
|
|
|
o |
|
o |
|
o |
IF THIS PROXY IS EXECUTED AND RETURNED BUT NO INSTRUCTION (OR AN UNCLEAR INSTRUCTION) IS MADE AS TO WHAT ACTION IS TO BE TAKEN, IT WILL BE DEEMED TO CONSTITUTE A VOTE FOR EACH OF THE PROPOSALS HERETO.
PLACE X HERE IF YOU PLAN TO ATTEND AND VOTE YOUR SHARES AT THE MEETING o
COMPANY ID:
PROXY NUMBER:
ACCOUNT NUMBER:
Signature |
|
Signature |
|
Date |
|
, 2017. |
NOTE: Please sign exactly as name appears hereon. When shares are held by joint owners, both should sign. When signing as an attorney, executor, administrator, trustee or guardian, please give title as such. If a corporation, please sign in full corporate name by President or other authorized officer. If a partnership, please sign in partnership name by authorized person.